Kiniksa Pharmaceuticals International Plc (KNSA)
47.77
+0.60
(+1.27%)
USD |
NASDAQ |
Feb 20, 16:00
48.29
+0.52
(+1.09%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International SG&A Expense (Quarterly) : 49.10M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 1.024M |
| NovoCure Ltd. | 104.47M |
| LivaNova Plc | 138.52M |
| ADMA Biologics, Inc. | 23.05M |
| Alterola Biotech, Inc. | -- |